Emerging therapies in advanced melanoma | 33 min
Emerging therapies in advanced melanomaThe management of metastatic melanoma is a rapidly changing field, with major advances in recent years making a significant improvement on the outcomes of patients with Stage IV melanoma. In this podcast, Medical Oncologist A/Prof Carlino is interviewed by A/Prof Menzies on the developments in targeted therapies and immunotherapies that are currently available and how they are changing the outlook of patients with advanced melanoma, including patients with brain metastases. They also discuss common complications and how to manage them.
This podcast is suitable for medical oncologists, surgical oncologists and radiation oncologists, and may also be of interest to GPs, oncology nurses and other healthcare practitioners.
A/Prof Matteo Carlino
Medical Oncologist, Melanoma Institute Australia, Westmead and Blacktown Hospitals | Clinical Associate Professor, The University of Sydney
A/Prof Alexander Menzies
Medical Oncologist, Melanoma Institute Australia, Royal North Shore and Mater Hospitals | Associate Professor of Melanoma Medical Oncology, The University of Sydney
1. Recall the systemic therapies currently available in Australia for the treatment of metastatic melanoma and their respective roles in treatment.
2. Identify and manage potential complications of the systemic therapies used in the treatment of metastatic melanoma.
3. Outline the role of systemic treatments in the treatment of brain metastases.